rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1977-8-12
|
pubmed:abstractText |
1. GTP and GMP-P(NH)P (guanyl-5'-yl imidodiphosphate) were observed to increase the stimulation of neural adenylate cyclase by dopamine (3,4-dihydroxyphenethylamine) and noradrenaline. 2. GMP-P(NH)P had a biphasic effect on the enzyme activity. 3. Preincubation of membranes with GMP-P(NH)P activated the enzyme by a process dependent on time and temperature. Catecholamines increased the speed and the extent of this activation. 4. Membrane fractions contained high- and low-affinity sites for GMP-P(NH)P binding: this binding was due to protein(s) of the membrane preparations. 5. Low-affinity-site binding of GMP-P(NH)P appeared to be related to the stimulatory effect on the adenylate cyclase activity.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-1057166,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-10890,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-10895,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-1120776,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-1126949,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-1186917,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-13061491,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-14907713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-166994,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-236641,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-4149993,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-4268121,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-4326768,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-4367725,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-4376216,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18147-820343
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0264-6021
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
67-74
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18147-Adenosine Triphosphate,
pubmed-meshheading:18147-Adenylate Cyclase,
pubmed-meshheading:18147-Animals,
pubmed-meshheading:18147-Binding Sites,
pubmed-meshheading:18147-Caudate Nucleus,
pubmed-meshheading:18147-Cerebral Cortex,
pubmed-meshheading:18147-Dopamine,
pubmed-meshheading:18147-Drug Synergism,
pubmed-meshheading:18147-Guanine Nucleotides,
pubmed-meshheading:18147-Guanosine Triphosphate,
pubmed-meshheading:18147-Hydrogen-Ion Concentration,
pubmed-meshheading:18147-Magnesium,
pubmed-meshheading:18147-Male,
pubmed-meshheading:18147-Norepinephrine,
pubmed-meshheading:18147-Rats,
pubmed-meshheading:18147-Stimulation, Chemical,
pubmed-meshheading:18147-Subcellular Fractions,
pubmed-meshheading:18147-Time Factors
|
pubmed:year |
1977
|
pubmed:articleTitle |
Catecholamine-sensitive adenylate cyclase of caudate nucleus and cerebral cortex. Effects of guanine nucleotides.
|
pubmed:publicationType |
Journal Article
|